Beyond Air, Inc. (NASDAQ: XAIR) shares are rocketing on Tuesday after the company disclosed a deal with XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) to sell 85% of its subsidiary company, NeuroNOS Ltd.
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results